Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1675960 | 1.00 | ADH1B (0.31) | ADH1BADH1CADH1AADH7 | |
| Hydrochloric Acid SCHEMBL4186024 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL4186022 | 0.97 | — | — | |
| SCHEMBL3804596 | 0.88 | EPHX1 (0.48) | ADH1BADH1CADH1AADH7 | |
| SCHEMBL8927773 | 0.88 | EPHX1 (0.48) | ADH1BADH1CADH1AADH7 | |
| SCHEMBL16595152 | 0.85 | — | — | |
| SCHEMBL12778663 | 0.78 | — | — | |
| SCHEMBL20334248 | 0.78 | EPHX1 (0.48) | ADH1BADH1CADH1AADH7 | |
| SCHEMBL13840828 | 0.76 | ADH1B (0.43) | ADH1BADH1CADH1AADH7 | |
| SCHEMBL24685196 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110091931-A1 | Methods and Kits for Determining Oxygen Free Radical (OFR) Levels in Animal and Human Tissues as a Prognostic Marker for Cancer and Other Pathophysiologies | COLBY PHARMACEUTICAL COMPANY (US) | 2011-04-21 | — | — | US | disclosed |
| WO-2010124257-A2 | METHODS AND KITS FOR DETERMINING OXYGEN FREE RADICAL (OFR) LEVELS IN ANIMAL AND HUMAN TISSUES AS A PROGNOSTIC MARKER FOR CANCER AND OTHER PATHOPHYSIOLOGIES | COLBY PHARMACEUTICAL COMPANY (US) | 2010-10-28 | — | — | WO | disclosed |
| EP-2026782-A2 | N1,N4-BIS(BUTA-1,3-DIENYL)BUTANE-1,4-DIAMINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Wisconsin Alumini Research Foundation (US) | 2009-02-25 | — | — | EP | disclosed |
| US-20080114072-A1 | Antioxidants; polyamine oxidase inhibitors; for preventing and/or treating prostate cancer in male humans; kits | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-05-15 | — | — | US | disclosed |
| WO-2007130589-A3 | NL, N4-BIS (BUTA-I, 3-DIENYL) BUTANE-I, 4-DIAMINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | WISCONSIN ALUMNI RES FOUND (US) | 2008-03-27 | — | — | WO | disclosed |
| WO-2007130589-A2 | NL, N4-BIS (BUTA-I, 3-DIENYL) BUTANE-I, 4-DIAMINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080114072-A1 | Antioxidants; polyamine oxidase inhibitors; for preventing and/or treating prostate cancer in male humans; kits | BPHL, AOC1, DDO | ADH1B 357/4885ADH1C 126/4885ADH1A 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.